Client programs using CHOMax follow platform-defined workflows and phase-appropriate practices across the development lifecycle.

Data presented at ASH 2025 suggest earlier-line use of cilta-cel leads to better outcomes in multiple myeloma because patients have fitter immune systems and less exhausted T cells, improving CAR T ...

Gene therapies offer incredible promise for treating diseases with a genetic component. Several gene therapies are already available, and adeno-associated virus (AAV) has become a popular choice for ...

Understanding why cancer cells rely on specific genes is critical for designing effective targeted therapies. A new study ...

Maxwell has officially signed a full-line supply contract for Perovskite/SHJ tandem cells with a Chinese new energy company, ...